Adam McCabe

AIM investor - Property Buyer - Renovator - Landlord - Bathroom connoisseur *Not in any particular order*

[Adam McCabe @AdamM_PI]

@PoolbegPharma research document

Please let me know if you find this useful - feedback is helpful.

This is a statement of facts - not Investment advice

#POLB #AIM #Investment
@HLInvest

[Adam McCabe @AdamM_PI]

#POLB

[Share_Talk ™ @Share_Talk]

@PoolbegPharma has the potential to transform cancer treatment. By moving #POLB administration of cancer immunotherapies away from centralised specialist cancer centres in large cities, into community hospitals & potentially into the patients GP practice
https://t.co/jq6lzVQQ4A

[Adam McCabe @AdamM_PI]

#POLB

[🇬🇧 𝑻𝒉𝒆 𝑫𝒐𝒄 🇨🇾 @DDS_DocHoliday]

ACT appointed for POLB 001 Phase 2a Trial and supply of approved bispecific antibody drug secured at no cost #POLB

https://t.co/GgXfTdnKN7

[Poolbeg Pharma @PoolbegPharma]

During our panel discussion at the @_investorsummit our CEO Jeremy Skillington discussed the benefits of Orphan Drug Designation (ODD) and how this award from the FDA significantly benefits POLB 001’s development.

👉7-year U.S. market exclusivity
💪Tax benefits for clinical trials
✅Potential waiver exemption of Prescription Drug User Fee Act application fees
📞Direct line to FDA around clinical trials

Learn more about our ODD announcement for POLB 001 here:
https://t.co/x4TT1KlNJw

#POLB #ODD #FDA #ScientificResearch #MarketExclusivity #ClinicalTrials #CRS #Immunotherapy #Cancer #Oncology

[Adam McCabe @AdamM_PI]

Soon be saying this again - 9 months on 😎

#POLB
@PoolbegPharma

[Adam McCabe @AdamM_PI]

#POLB 5p paid 😎

[Adam McCabe @AdamM_PI]

#POLB

[Poolbeg Pharma @PoolbegPharma]

Tune into our snippet from CEO Jeremy Skillington, who provides a timeline for POLB 001’s milestones

✅Trial to commence before the end 2025
☑️Interim data in H1 2026
🚀Trial completion by H2 2026
🤝Take datasets, intellectual property to partnering with Big Pharma
➡️ODD accelerates progression into the clinic
👉Potential to go to a straight into a Phase 3

Learn more about POLB 001, a Preventative Therapy Targeting Cancer Immunotherapy-Induced CRS:
https://t.co/xDBLqtZIB4

#POLB #InvestorSummit #CRS #Immunotherapy #Treatments #ScientificResearch #Oncology #CytokineReleaseSyndrome #Inflammation

[Poolbeg Pharma @PoolbegPharma]

Poolbeg Pharma is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs.

We are led by a team dedicated to improving global health and with a track record of success in the pharmaceutical industry.

Our high value programmes target areas of high unmet medical need including cancer immunotherapy-induced Cytokine release Syndrome (CRS) and metabolic conditions such as obesity with our oral encapsulated GLP-1 programme.

In May 2025, we had an oversubscribed fundraise, which resulted in us having a strong cash runway into 2027, funding our near-term clinical value inflection points in oncology and obesity.

We are partnering focused, with programmes that are attractive for Pharma partnering.

Learn more:
https://t.co/4eqcMhz6hs

#POLB #Investors #ReasonstoInvest #AIM #Market #Pharma

[Adam McCabe @AdamM_PI]

#POLB

[Share_Talk ™ @Share_Talk]

It could be argued that the share price of #POLB went the wrong way in a big way following the announcement of what should have been regarded as a stellar deal with HOOKIPA. It seems that the market is starting to warm to the proposed combo. @ZaksTradersCafe

[Adam McCabe @AdamM_PI]

#POLB 5p paid 😎

[Adam McCabe @AdamM_PI]

Nearly pushing 5p @PoolbegPharma

Plenty more to go

#POLB

Excited about this one from these lows 🤪

[Adam McCabe @AdamM_PI]

I see #POLB heading to 5p this afternoon with this morning vote of confidence by Gilead @GileadSciences

$Hookipa will move on US open

Pushing @PoolbegPharma higher

Bid creeping 📈

Good luck all 😎

[Adam McCabe @AdamM_PI]

#POLB

[Vox Markets @VOXmarkets]

Poolbeg and HOOKIPA merger backed by Gilead Sciences, POLB shares gain #POLB @PoolbegPharma

https://t.co/iv2tF5dYBJ #investing #shares #voxmarkets via @VOXmarkets

[Adam McCabe @AdamM_PI]

@investwisely321 Hi mate, no - please could you send it?

Many thanks.

[Adam McCabe @AdamM_PI]

Is there a #polb telegram group?

[Adam McCabe @AdamM_PI]

I see #POLB heading to 5p this afternoon with this morning vote of confidence by Gilead @GileadSciences

$Hookipa will move on US open

Pushing @PoolbegPharma higher

Bid creeping 📈

Good luck all 😎

[Adam McCabe @AdamM_PI]

Remember when everyone was complaining about #TM1 ?

Similar to #RBD

It’s coming 📈

@ReaboldPLC

Cash in the bank 💰

Multiple long term projects 👷🏼‍♂️

Low low MCap 📉

New due 🗞️

All I hear is greedy directors

Greedy directors that bought @ 0.07

They won’t be losing out

[Adam McCabe @AdamM_PI]

Some clarity on the liquidation of #Made

First interim payment to be made by month end

1.36p per share

Fingers crossed for a tidy final payment
@madedotcom

[🐒tozzer🐒 @tozzer121]

@iamTomOrange @power_thompson It's a classic nobody wants em til everybody does and at sub £5 mill mcap with £7+mill cash any news sends it on it'd way

In the meantime buy cheap cheap and stay in the long grass #RBD

[Adam McCabe @AdamM_PI]

#RBD it’ll come

[Early_Bird @Early_Bird97]

#RBD now priced sub £5m cap with over £7m in cash....

Frustrating hold but things should start moving soon

https://t.co/MsaeUBr374